174 related articles for article (PubMed ID: 19207832)
1. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies.
Valentini CG; Candoni A; Fianchi L; Posteraro B; Simeone E; Costa F; Sanguinetti M; Voso MT; Caira M; Fanin R; Pagano L
Mycoses; 2010 Jan; 53(1):89-92. PubMed ID: 19207832
[TBL] [Abstract][Full Text] [Related]
2. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
[TBL] [Abstract][Full Text] [Related]
3. ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies.
Pagano L; Valentini CG; Caira M; Fianchi L
Br J Haematol; 2009 Sep; 146(6):597-606. PubMed ID: 19466966
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.
Cooke DT; Pagani FD; Kaul DR; Cooke KR; Lau CL; Riddell J
Mycoses; 2010 Mar; 53(2):163-7. PubMed ID: 19207843
[No Abstract] [Full Text] [Related]
5. [Invasive zygomycosis in patients treated for haematological malignancies].
Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258
[TBL] [Abstract][Full Text] [Related]
6. Current experience in treating invasive zygomycosis with posaconazole.
Cornely OA; Vehreschild JJ; Rüping MJ
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():77-81. PubMed ID: 19754763
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous zygomycosis.
Bonifaz A; Vázquez-González D; Tirado-Sánchez A; Ponce-Olivera RM
Clin Dermatol; 2012; 30(4):413-9. PubMed ID: 22682190
[TBL] [Abstract][Full Text] [Related]
8. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
[TBL] [Abstract][Full Text] [Related]
9. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
10. [Mucormycosis: therapeutic news].
Pilmis B; Lanternier F; Lortholary O
Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
[TBL] [Abstract][Full Text] [Related]
11. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Paul S; Marty FM; Colson YL
Ann Thorac Surg; 2006 Jul; 82(1):338-40. PubMed ID: 16798251
[TBL] [Abstract][Full Text] [Related]
13. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases.
Shoham S; Magill SS; Merz WG; Gonzalez C; Seibel N; Buchanan WL; Knudsen TA; Sarkisova TA; Walsh TJ
Med Mycol; 2010 May; 48(3):511-7. PubMed ID: 19824881
[TBL] [Abstract][Full Text] [Related]
14. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery.
Revankar SG; Hasan MS; Smith JW
Med Mycol; 2007 Mar; 45(2):183-5. PubMed ID: 17365655
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of cutaneous zygomycosis.
Visser DH; van den Berg YL; van Furth AM; Oomen MW; Schouten-van Meeteren AY; Pajkrt D; van den Bos C; van Well GT
Pediatr Infect Dis J; 2007 Dec; 26(12):1165-6. PubMed ID: 18043463
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman.
Stewardson AJ; Holmes NE; Ellis DH; Howden BP
Mycoses; 2009 Nov; 52(6):547-9. PubMed ID: 19682315
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
Peterson L; Ostermann J; Rieger H; Ostermann H; Rieger CT
Mycoses; 2013 Nov; 56(6):651-8. PubMed ID: 23710592
[TBL] [Abstract][Full Text] [Related]
18. Favourable outcome of pulmonary zygomycosis in haematological malignancy.
Opeskin K; Sheorey H; Wright G; Nandurkar H
Pathology; 2006 Jun; 38(3):271-3. PubMed ID: 16753758
[No Abstract] [Full Text] [Related]
19. An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections.
Almaslamani M; Taj-Aldeen SJ; Garcia-Hermoso D; Dannaoui E; Alsoub H; Alkhal A
Med Mycol; 2009; 47(5):532-8. PubMed ID: 19184768
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous zygomycosis.
Skiada A; Petrikkos G
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():41-5. PubMed ID: 19754756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]